The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers ...

Visual hallucinations affect up to 75% of Parkinson’s patients, causing them to see people and animals that aren’t really there. Now, medication that targets these hallucinations, through a different ...

The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom ...

Neuroendocrine tumors (NETs) develop from neurosecretory cells affecting organs like the gastrointestinal tract and lungs. These tumors often cause ho ...

Melatonin MT1 brain receptor has a pivotal role in this entire process of switching the brain from the alert stage to the ...

So Copenhagen University psychologist Vibeke Dam and colleagues took a closer look at the drug's impacts on 90 patients with ...

Neurotransmitters are chemical messengers that have excitatory, inhibitory, and modulatory actions. Learn what they are and ...

Melatonin MT1 receptor plays a crucial role in regulating REM sleep. A novel drug could extend REM sleep without negative ...

Researchers have not only found a dream switch but may have figured out how to flip it, potentially transforming sleep medicine as we know it.

A recent study from the Research Institute at McGill University Health Center may improve the treatment of sleep disorders ...

Dopamine was long thought to play a part in the placebo effect for pain relief, but a new study is questioning its true role ...

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...